353 related articles for article (PubMed ID: 18259840)
1. Targeting PTPs with small molecule inhibitors in cancer treatment.
Jiang ZX; Zhang ZY
Cancer Metastasis Rev; 2008 Jun; 27(2):263-72. PubMed ID: 18259840
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatases, new targets for cancer therapy.
Easty D; Gallagher W; Bennett DC
Curr Cancer Drug Targets; 2006 Sep; 6(6):519-32. PubMed ID: 17017875
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.
Frankson R; Yu ZH; Bai Y; Li Q; Zhang RY; Zhang ZY
Cancer Res; 2017 Nov; 77(21):5701-5705. PubMed ID: 28855209
[TBL] [Abstract][Full Text] [Related]
4. Druggable targets of protein tyrosine phosphatase Family, viz. PTP1B, SHP2, Cdc25, and LMW-PTP: Current scenario on medicinal Attributes, and SAR insights.
Bhavana ; Kohal R; Kumari P; Das Gupta G; Kumar Verma S
Bioorg Chem; 2024 Mar; 144():107121. PubMed ID: 38237392
[TBL] [Abstract][Full Text] [Related]
5. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
He R; Zeng LF; He Y; Zhang S; Zhang ZY
FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
[TBL] [Abstract][Full Text] [Related]
6. Small molecule targeting of PTPs in cancer.
Lazo JS; McQueeney KE; Burnett JC; Wipf P; Sharlow ER
Int J Biochem Cell Biol; 2018 Mar; 96():171-181. PubMed ID: 28943273
[TBL] [Abstract][Full Text] [Related]
7. Targeting protein tyrosine phosphatases for anticancer drug discovery.
Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
[TBL] [Abstract][Full Text] [Related]
8. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
Krabill AD; Zhang ZY
Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
[TBL] [Abstract][Full Text] [Related]
9. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
[TBL] [Abstract][Full Text] [Related]
10. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
Zhang ZY
Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
[TBL] [Abstract][Full Text] [Related]
11. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatases as potential therapeutic targets.
He RJ; Yu ZH; Zhang RY; Zhang ZY
Acta Pharmacol Sin; 2014 Oct; 35(10):1227-46. PubMed ID: 25220640
[TBL] [Abstract][Full Text] [Related]
13. Impact of oncogenic protein tyrosine phosphatases in cancer.
Hardy S; Julien SG; Tremblay ML
Anticancer Agents Med Chem; 2012 Jan; 12(1):4-18. PubMed ID: 21707506
[TBL] [Abstract][Full Text] [Related]
14. Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B.
Lee S; Wang Q
Med Res Rev; 2007 Jul; 27(4):553-73. PubMed ID: 17039461
[TBL] [Abstract][Full Text] [Related]
15. High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators.
Mattila E; Ivaska J
Anticancer Agents Med Chem; 2011 Jan; 11(1):141-50. PubMed ID: 21288196
[TBL] [Abstract][Full Text] [Related]
16. A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis.
Adams J; Thornton BP; Tabernero L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830087
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma.
Ruckert MT; de Andrade PV; Santos VS; Silveira VS
Cell Mol Life Sci; 2019 Jul; 76(13):2571-2592. PubMed ID: 30982078
[TBL] [Abstract][Full Text] [Related]
18. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
[TBL] [Abstract][Full Text] [Related]
19. Natural products with protein tyrosine phosphatase inhibitory activity.
Carr G; Berrue F; Klaiklay S; Pelletier I; Landry M; Kerr RG
Methods; 2014 Jan; 65(2):229-38. PubMed ID: 24056213
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions.
Reddy RH; Kim H; Cha S; Lee B; Kim YJ
J Microbiol Biotechnol; 2017 May; 27(5):878-895. PubMed ID: 28238001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
